Skip to main content
Elsevier - PMC Mpox Collection logoLink to Elsevier - PMC Mpox Collection
. 2022 Dec 1;400(10367):1926. doi: 10.1016/S0140-6736(22)02414-X

Department of Error

PMCID: PMC9714977  PMID: 36463905

The content is available as a PDF (118.5 KB).

Acknowledgments

Mitjà O, Ogoina D, Titanji BK, et al. Monkeypox. Lancet 2022; published online Nov 17. https://doi.org/10.1016/S0140-6736(22)02075-X—In this Seminar, the section on Treatment in the unanswered research questions panel should read “Should early initiation of treatment and an extended duration of treatment be recommended for individuals who are highly immunocompromised (eg, HIV with a CD4 count <200)?” This correction has been made to the online version as of Dec 1, 2022, and will be made to the printed version.


Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES